| 2026-09-11 | acupuncture-aromatase-inhibitor-arthralgia, retifanlimab, b-combination-space, basement-membrane-tissue-barriers, kenneth-kinzler, cbt-fatigue-distress, multidisciplinary-tumour-board | Seven cited DOIs did not resolve (mistyped or belonging to another article); the intended papers were re-identified through Crossref with journal and DOI prefix pinned, for example POD1UM-303 to 10.1016/S0140-6736(25)00631-2 and the FAP locus paper to 10.1126/science.1651562. Two more (rEECur, NUT carcinoma registry) could not be identified and were removed; the small bowel adenocarcinoma guideline DOI now points at the ASCO guidelines index. | Link check (doi.org 404) | URLs corrected |
| 2026-09-11 | 46 records with a Wikipedia link, 13 with a Wikipedia-only source | The Wikipedia article title in wikipedia or links no longer exists (for example Oncotype_DX, PSMA_PET, Immuno-PET). Titles were checked against the Wikipedia API; one was renamed (Biosecure Act), the rest removed. BCLC staging and cardio-oncology now cite their primary guideline papers instead. | Link check (404) | references removed or replaced |
| 2026-09-11 | 33 dead pages (fda.gov, cancer.gov, institutional and company pages) | Pages returned 404 to a browser as well as to the checker; replaced with the nearest Wayback Machine snapshot and labelled "(archived copy)". 45 pages whose publisher moved them now point at the nearest live section of the same site, labelled "(page moved; nearest live section)"; 101 dead links on records that keep another source were removed. accessdata.fda.gov and doi.org answer non-browser clients with 404 or 403, so those were verified with a browser user agent and left as they were. | Link check | URLs replaced or removed |
| 2026-09-11 | elevate-tn | nct was NCT02475097, which does not exist on ClinicalTrials.gov; the acalabrutinib ELEVATE-TN study is NCT02475681 (acronym ElevateTN). | Registry fact check (nct-not-found), confirmed against the registry entry | set to NCT02475681 |
| 2026-09-11 | ace-breast-02 | nct was NCT04829604, which is the separate US phase 2 study ACE-Breast-03 (72 patients); ACE-Breast-02 is registered in China only. | Registry fact check: phase and enrolment disagreed, registry title names ACE-Breast-03 | id removed; the primary publication is the source |
| 2026-09-11 | preopanc | nct was NCT02172976, a 40-patient German gemcitabine versus FOLFIRINOX study, not the Dutch PREOPANC trials. | Registry fact check: enrolment 40 versus 246 and a different title | set to NTR3709 (Netherlands Trial Register) and cite the JCO 2020 and JCO 2022 papers |
| 2026-09-11 | iberdomide | Status "phase-3" with no US approval; openFDA holds the Zenbexus label, effective 13 August 2026, for relapsed myeloma with daratumumab and dexamethasone. | Registry fact check (openFDA label exists, not recorded as approved) | status approved, approvals row and DailyMed link added; regional table updated |
| 2026-09-11 | daraxonrasib | regional-approvals.ts still said "under review" while the record and the FDA novel approvals page record approval on 26 August 2026 (Rasonque). | Audit (approvals disagree with the regional table) | regional row set to approved 2026 |
| 2026-09-11 | nintedanib | Status "negative" although the EMA authorised Vargatef for lung adenocarcinoma with docetaxel in 2014; the mesothelioma failure is one programme, not the molecule's status. | Audit (status disagrees with approvals) | status approved, EMA EPAR linked, TL;DR reworded |
| 2026-09-11 | atrt, chordoma, epithelioid-sarcoma, epigenetics-roadmap | Standard-of-care rows, pipelines and a roadmap step still presented tazemetostat as available; Ipsen withdrew it from all markets in March 2026. | Audit (standard of care and pipeline cite a withdrawn item) | rows reworded to state the withdrawal, removed from pipelines, roadmap step notes it |
| 2026-09-11 | mds | Pipeline listed magrolimab, stopped in 2024. | Audit (pipeline cites a withdrawn item) | removed |
| 2026-09-11 | hairy-cell-leukemia | Row said moxetumomab pasudotox "where still available"; it was withdrawn from sale in 2023. | Audit (standard of care cites a withdrawn item) | reworded |
| 2026-09-11 | docetaxel, durvalumab, ibrutinib, lenalidomide, pegylated-liposomal-doxorubicin, temsirolimus, dabrafenib-trametinib | approvals[] began later than the first approval: docetaxel 1996 (Taxotere, breast), durvalumab 2017 (urothelial, accelerated), ibrutinib US 2013 (MCL) and EU 2014, lenalidomide 2005 (MDS del(5q)), Doxil 1995 (Kaposi sarcoma); temsirolimus EU year was 2009 (Torisel authorised November 2007, MCL added 2009); the dabrafenib plus trametinib combination was approved in the US in January 2014 (regional table said 2013, the single agents). | Audit (approvals disagree with the regional table) and Drugs@FDA earliest original approval | rows added or corrected |
| 2026-09-11 | lacc | Text quoted a death hazard ratio of 6.00 while the only structured outcome carried the disease-free survival HR 3.74. | Audit (number in the text disagrees with the structured field) | overall survival outcome added from NEJM 2018 |
| 2026-09-11 | peace-1 | Result gave only the overall-population OS HR 0.82 while the structured outcome carried the ADT plus docetaxel population HR 0.75. | Audit (number in the text disagrees with the structured field) | result states both populations |
| 2026-09-11 | bevacizumab, cabozantinib, everolimus, ivosidenib, lenvatinib, letrozole, ramucirumab, regorafenib, sunitinib, trabectedin, Eisai, Exelixis, Incyte | Each was defined in full by two or three cancer deep dives with different summaries, mechanisms and approval rows; only the first copy was ever shown and the rest were silently hidden. | Audit (duplicates with different values) | second copies became supplements: relationship arrays, extra approval rows and cancer-specific facts as notes |
| 2026-09-11 | alfa-0701 | enrolled was "271"; the registry says 280 (ACTUAL). | Registry fact check (source) | set to "280" via apply-factcheck |
| 2026-09-11 | alter-0303 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | amplify-7p | phase was "2"; the registry says PHASE1/PHASE2. | Registry fact check (source) | set to "1/2" via apply-factcheck |
| 2026-09-11 | apt-trial | enrolled was "410"; the registry says 406 (ACTUAL). | Registry fact check (source) | set to "406" via apply-factcheck |
| 2026-09-11 | ascertain-v | phase was "2"; the registry says PHASE1/PHASE2. | Registry fact check (source) | set to "1/2" via apply-factcheck |
| 2026-09-11 | belinda | enrolled was "322"; the registry says 330 (ACTUAL). | Registry fact check (source) | set to "330" via apply-factcheck |
| 2026-09-11 | camel | enrolled was "412"; the registry says 419 (ACTUAL). | Registry fact check (source) | set to "419" via apply-factcheck |
| 2026-09-11 | cartitude-5 | status was "recruiting"; the registry says ACTIVE_NOT_RECRUITING. | Registry fact check (source) | set to "active" via apply-factcheck |
| 2026-09-11 | checkmate-9dw | enrolled was "668"; the registry says 732 (ACTUAL). | Registry fact check (source) | set to "732" via apply-factcheck |
| 2026-09-11 | checkmate-9er | enrolled was "651"; the registry says 701 (ACTUAL). | Registry fact check (source) | set to "701" via apply-factcheck |
| 2026-09-11 | cll14 | enrolled was "432"; the registry says 445 (ACTUAL). | Registry fact check (source) | set to "445" via apply-factcheck |
| 2026-09-11 | anbl0532 | enrolled was "652"; the registry says 665 (ACTUAL). | Registry fact check (source) | set to "665" via apply-factcheck |
| 2026-09-11 | compete | enrolled was "309"; the registry says 324 (ACTUAL). | Registry fact check (source) | set to "324" via apply-factcheck |
| 2026-09-11 | desktop-iii | enrolled was "407"; the registry says 408 (ACTUAL). | Registry fact check (source) | set to "408" via apply-factcheck |
| 2026-09-11 | destiny-breast12 | enrolled was "504"; the registry says 506 (ACTUAL). | Registry fact check (source) | set to "506" via apply-factcheck |
| 2026-09-11 | dreamseq | enrolled was "265"; the registry says 267 (ACTUAL). | Registry fact check (source) | set to "267" via apply-factcheck |
| 2026-09-11 | emerald-3 | enrolled was "725"; the registry says 760 (ACTUAL). | Registry fact check (source) | set to "760" via apply-factcheck |
| 2026-09-11 | epcore-nhl-1 | phase was "2"; the registry says PHASE1/PHASE2. | Registry fact check (source) | set to "1/2" via apply-factcheck |
| 2026-09-11 | foenix-cca2 | phase was "2"; the registry says PHASE1/PHASE2. | Registry fact check (source) | set to "1/2" via apply-factcheck |
| 2026-09-11 | golseek-1 | status was "recruiting"; the registry says ACTIVE_NOT_RECRUITING. | Registry fact check (source) | set to "active" via apply-factcheck |
| 2026-09-11 | her2climb-02 | enrolled was "463"; the registry says 466 (ACTUAL). | Registry fact check (source) | set to "466" via apply-factcheck |
| 2026-09-11 | herizon-gea-01 | enrolled was "914"; the registry says 920 (ACTUAL). | Registry fact check (source) | set to "920" via apply-factcheck |
| 2026-09-11 | horizon-breast01 | enrolled was "366"; the registry says 381 (ACTUAL). | Registry fact check (source) | set to "381" via apply-factcheck |
| 2026-09-11 | imroz | enrolled was "446"; the registry says 475 (ACTUAL). | Registry fact check (source) | set to "475" via apply-factcheck |
| 2026-09-11 | inavo120 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | keynote-483 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | ion-trial | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | izabright-breast01 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | lacc | enrolled was "631"; the registry says 636 (ACTUAL). | Registry fact check (source) | set to "636" via apply-factcheck |
| 2026-09-11 | legend-2 | phase was "1"; the registry says PHASE1/PHASE2. | Registry fact check (source) | set to "1/2" via apply-factcheck |
| 2026-09-11 | lidera | enrolled was "4200"; the registry says 4170 (ACTUAL). | Registry fact check (source) | set to "4170" via apply-factcheck |
| 2026-09-11 | litespark-005 | enrolled was "746"; the registry says 755 (ACTUAL). | Registry fact check (source) | set to "755" via apply-factcheck |
| 2026-09-11 | lume-meso | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | maps | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | matterhorn | enrolled was "948"; the registry says 957 (ACTUAL). | Registry fact check (source) | set to "957" via apply-factcheck |
| 2026-09-11 | mevpro-1 | status was "recruiting"; the registry says ACTIVE_NOT_RECRUITING. | Registry fact check (source) | set to "active" via apply-factcheck |
| 2026-09-11 | orient-32 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | orient-32 | enrolled was "571"; the registry says 595 (ACTUAL). | Registry fact check (source) | set to "595" via apply-factcheck |
| 2026-09-11 | outback | enrolled was "919"; the registry says 926 (ACTUAL). | Registry fact check (source) | set to "926" via apply-factcheck |
| 2026-09-11 | persevera | enrolled was "978"; the registry says 992 (ACTUAL). | Registry fact check (source) | set to "992" via apply-factcheck |
| 2026-09-11 | phergain | enrolled was "356"; the registry says 377 (ACTUAL). | Registry fact check (source) | set to "377" via apply-factcheck |
| 2026-09-11 | quilt-3-032 | phase was "2"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | rxponder | enrolled was "5083"; the registry says 5018 (ACTUAL). | Registry fact check (source) | set to "5018" via apply-factcheck |
| 2026-09-11 | senticol-iii | status was "recruiting"; the registry says ACTIVE_NOT_RECRUITING. | Registry fact check (source) | set to "active" via apply-factcheck |
| 2026-09-11 | stellar | enrolled was "80"; the registry says 82 (ACTUAL). | Registry fact check (source) | set to "82" via apply-factcheck |
| 2026-09-11 | viale-a | enrolled was "431"; the registry says 443 (ACTUAL). | Registry fact check (source) | set to "443" via apply-factcheck |
| 2026-09-11 | waveline-003 | phase was "3"; the registry says PHASE2/PHASE3. | Registry fact check (source) | set to "2/3" via apply-factcheck |
| 2026-09-11 | her2climb | phase was "3"; the registry says PHASE2. | Registry fact check (source) | set to "2" via apply-factcheck |
| 2026-09-11 | imcgp100-202 | phase was "3"; the registry says PHASE2. | Registry fact check (source) | set to "2" via apply-factcheck |
| 2026-09-11 | ken-she | phase was "3"; the registry says PHASE4. | Registry fact check (source) | set to "4" via apply-factcheck |
| 2026-09-11 | amplify-7p | enrolled was "144"; the registry says 158 (ACTUAL). | Registry fact check (source) | set to "158" in trial-outcomes.ts |
| 2026-09-11 | eortc-26981 | enrolled was "573"; the registry says 575 (ACTUAL). | Registry fact check (source) | set to "575" in trial-outcomes.ts |
| 2026-09-11 | keynote-355 | enrolled was "847"; the registry says 882 (ACTUAL). | Registry fact check (source) | set to "882" in trial-outcomes.ts |
| 2026-09-11 | litespark-012 | enrolled was "1688"; the registry says 1854 (ACTUAL). | Registry fact check (source) | set to "1854" in trial-outcomes.ts |
| 2026-09-11 | pathfinder-2 | enrolled was "35878"; the registry says 35883 (ACTUAL). | Registry fact check (source) | set to "35883" in trial-outcomes.ts |
| 2026-09-11 | rasolute-302 | enrolled was "460"; the registry says 500 (ACTUAL). | Registry fact check (source) | set to "500" in trial-outcomes.ts |
| 2026-09-11 | tropion-breast03 | enrolled was "1075"; the registry says 1174 (ACTUAL). | Registry fact check (source) | set to "1174" in trial-outcomes.ts |
| 2026-09-11 | tropion-lung01 | enrolled was "604"; the registry says 605 (ACTUAL). | Registry fact check (source) | set to "605" in trial-outcomes.ts |
| 2026-09-11 | flaura2 | enrolled was "557"; the registry says 587 (ACTUAL). | Registry fact check (source) | set to "587" in trial-outcomes.ts |
| 2026-09-11 | impassion131 | enrolled was "651"; the registry says 653 (ACTUAL). | Registry fact check (source) | set to "653" in trial-outcomes.ts |
| 2026-09-11 | latitude | enrolled was "1199"; the registry says 1209 (ACTUAL). | Registry fact check (source) | set to "1209" in trial-outcomes.ts |
| 2026-09-11 | olympia | enrolled was "1836"; the registry says 1837 (ACTUAL). | Registry fact check (source) | set to "1837" in trial-outcomes.ts |
| 2026-09-11 | psmafore | enrolled was "468"; the registry says 469 (ACTUAL). | Registry fact check (source) | set to "469" in trial-outcomes.ts |
| 2026-09-11 | splash | enrolled was "412"; the registry says 455 (ACTUAL). | Registry fact check (source) | set to "455" in trial-outcomes.ts |
| 2026-09-11 | therap | enrolled was "200"; the registry says 201 (ACTUAL). | Registry fact check (source) | set to "201" in trial-outcomes.ts |
| 2026-09-11 | vision | enrolled was "831"; the registry says 861 (ACTUAL). | Registry fact check (source) | set to "861" in trial-outcomes.ts |
| 2026-09-11 | xalute | enrolled was "675"; the registry says 707 (ACTUAL). | Registry fact check (source) | set to "707" in trial-outcomes.ts |
